Erratum to combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Publicado no Transl Lung Cancer Res (2017)

Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells

Por Ruan, Jhen-Wei, Liao, Yi-Chu, Lua, Ingrid, Li, Ming-Hsun, Hsu, Chih-Yi, Chen, Ji-Hshiung
Publicado em 2012

A promising result of locoregional tumor control with biologically adaptive radiotherapy in patients with locally advanced non-small cell lung cancer

Por Matsuo, Yukinori
Publicado no Transl Lung Cancer Res (2018)

Nivolumab as first line monotherapy for advanced non-small cell lung cancer: could we replace first line chemotherapy with immunotherapy?

Por West, Howard
Publicado no Transl Lung Cancer Res (2014)

Targeting the metastatic niche through anti-angiogenic approaches in epidermal growth factor receptor mutant non-small cell lung cancer

Por Tan, Wan Ling, Tan, Daniel S. W.
Publicado no Transl Lung Cancer Res (2018)

Professor Fred R. Hirsch, the IASLC CEO—showing you around the 18th World Conference on Lung Cancer (WCLC 2017)

Por Ma, Lynn, He, Chao-Xiu(Melanie
Publicado no Transl Lung Cancer Res (2018)

Cloning of Mouse DAN cDNA and Its Down‐regulation in Transformed Cells

Por Ozaki, Toshinori, Ma, Jun, Takenaga, Keizo, Sakiyama, Shigeru
Publicado no Jpn J Cancer Res (1996)

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential...

Por Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Monaco, Fabio, Guida, Cesare
Publicado no Transl Lung Cancer Res (2016)

Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor—resistant non-small cell lung cancer

Por Jiang, Tao, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2014)

Is overall survival still the primary endpoint in maintenance non-small cell lung cancer studies? An analysis of phase III randomised trials

Por Petrelli, Fausto, Barni, Sandro
Publicado no Transl Lung Cancer Res (2013)

Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein

Por Liu, Tao, Li, Wei-Miao, Wang, Wu-Ping, Sun, Ying, Ni, Yun-Feng, Xing, Hao, Xia, Jing-Hua, Wang, Xue-Jiao, Zhang, Zhi-Pei, Li, Xiao-Fei
Publicado no Am J Transl Res (2016)

Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery

Por Feng, Po-Hao, Yu, Chih-Teng, Wu, Chin-Yang, Lee, Meng-Jung, Lee, Wei-Hwa, Wang, Liang-Shun, Lin, Shu-Min, Fu, Jen-Fen, Lee, Kang-Yun, Yen, Tzung-Hai
Publicado em 2014

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

Por Gridelli, Cesare, Ardizzoni, Andrea, Barberis, Massimo, Cappuzzo, Federico, Casaluce, Francesca, Danesi, Romano, Troncone, Giancarlo, De Marinis, Filippo
Publicado no Transl Lung Cancer Res (2017)

The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer

Por Liang, Hengrui, Pan, Zhenkui, Cai, Xiuyu, Wang, Wei, Guo, Chengye, He, Jiaxi, Chen, Yuehan, Liu, Zhichao, Wang, Bo, He, Jianxing, Liang, Wenhua
Publicado no Transl Lung Cancer Res (2018)

miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition

Por Guo, Huihui, Zhang, Xilin, Chen, Qiuqiang, Bao, Ying, Dong, Chaohui, Wang, Xiang
Publicado no Am J Transl Res (2018)

Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease

Por Hoa, Neil T, Ge, Lisheng, Tajhya, Rajeev B, Beeton, Christine, Cornforth, Andrew N, Abolhoda, Amir, Lambrecht, Nils, DaCosta-Iyer, Maria, Ouyang, Yi, Mai, Anthony P, Hong, Erin, Shon, Judy, Hickey, Michelle J, Erickson, Kate L, Kruse, Carol A, Jadus, Martin R
Publicado em 2014

P25. In vitro evaluation of the anticancer activity of ganetespib in combination with standard chemotherapeutics in small cell lung cancer (SCLC) cell lines

Por Hamilton, Gerhard, Rath, Barbara, Maritschnegg, Elisabeth, Zeillinger, Robert
Publicado no Transl Lung Cancer Res (2014)

Effect of Korean Red Ginseng extract on colorectal lung metastasis through inhibiting...

Por Kee, Ji-Ye, Han, Yo-Han, Mun, Jeong-Geon, Park, Seong-Hwan, Jeon, Hee Dong, Hong, Seung-Heon
Publicado no J Ginseng Res (2019)

Ambroxol enhances anti-cancer effect of microtubule-stabilizing drug to lung carcinoma through blocking autophagic flux in lysosome-dependent way

Por Zhang, Xiulei, Chen, Qinyue, Chen, Meiyu, Ren, Xiaoqing, Wang, Xiaofei, Qian, Jianghui, Sun, Yali, Sha, Xianyi
Publicado no Am J Cancer Res (2017)

Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin

Por Devapatla, Bharat, Shidal, Chris, Yaddanapudi, Kavitha, Davis, Keith R.
Publicado no F1000Res (2017)